View Older Stories View More Recent Stories

Apr 24, 2025 09:06AM Texas Instruments (TXN) PT Lowered to $170 at Cantor Fitzgerald
Apr 24, 2025 09:04AM Cantor Fitzgerald Reiterates Overweight Rating on Impinj Inc (PI)
Apr 24, 2025 09:02AM Cantor Fitzgerald Reiterates Overweight Rating on ServiceNow (NOW)
Apr 24, 2025 08:57AM Cantor Fitzgerald Reiterates Overweight Rating on CyberArk Software (CYBR)
Apr 24, 2025 08:55AM Fortinet (FTNT) PT Lowered to $100 at Cantor Fitzgerald
Apr 23, 2025 06:08PM New Providence Acquisition Corp. III Announces the Pricing of $261,000,000 Initial Public Offering
Apr 23, 2025 09:43AM Cantor Fitzgerald Reiterates Overweight Rating on aTyr Pharma (ATYR)
Apr 23, 2025 09:40AM Cantor Fitzgerald Reiterates Overweight Rating on Travere Therapeutics (TVTX)
Apr 23, 2025 09:39AM Cantor teams up with Tether, Softbank for $3.6 billion crypto venture
Apr 23, 2025 09:38AM Cantor Fitzgerald Reiterates Overweight Rating on Summit Therapeutics plc (SMMT)
Apr 23, 2025 09:36AM Cantor Fitzgerald Reiterates Overweight Rating on Tourmaline Bio (TRML)
Apr 23, 2025 09:30AM Tether, SoftBank Group, and Jack Mallers Launch Twenty One, a Bitcoin-native Company, Through a Business Combination With Cantor Equity Partners (CEP)
Apr 23, 2025 09:29AM Cantor Fitzgerald Reiterates Overweight Rating on Elevance (ELV)
Apr 23, 2025 09:27AM Tether, SoftBank Group, and Jack Mallers Launch Twenty One, a Bitcoin-native Company, Through a Business Combination With Cantor Equity Partners
Apr 23, 2025 09:25AM Tesla (TSLA) PT Lowered to $355 at Cantor Fitzgerald
Apr 23, 2025 06:00AM Form 424B3 Cantor Fitzgerald Income
Apr 22, 2025 08:55PM Cantor nears $3 billion crypto venture with SoftBank and Tether, FT reports
Apr 22, 2025 10:41AM H.C. Wainwright & Co., LLC Announces the Hiring of Elemer Piros and Brandon Folkes as Senior Research Analysts, and Expansion of Institutional Sales Team
Apr 22, 2025 08:11AM Cantor Fitzgerald Reiterates Overweight Rating on Eli Lilly (LLY)
Apr 22, 2025 08:09AM Cantor Fitzgerald Reiterates Overweight Rating on Regeneron Pharma (REGN)
Apr 22, 2025 08:06AM Cantor Fitzgerald Reiterates Overweight Rating on Vertex (VRTX)
Apr 22, 2025 08:05AM Cantor Fitzgerald Reiterates Overweight Rating on Gilead Sciences (GILD)
Apr 22, 2025 08:03AM Cantor Fitzgerald Reiterates Neutral Rating on Amgen (AMGN)
Apr 22, 2025 07:59AM Cantor Fitzgerald Reiterates Overweight Rating on Stratasys Inc. (SSYS)
Apr 22, 2025 07:24AM Cantor Fitzgerald Assumes Vertex (VRTX) at Overweight
Apr 22, 2025 07:23AM Cantor Fitzgerald Assumes Regeneron Pharma (REGN) at Overweight
Apr 22, 2025 07:23AM Cantor Fitzgerald Starts Pfizer (PFE) at Neutral
Apr 22, 2025 07:22AM Cantor Fitzgerald Starts Vaxcyte (PCVX) at Overweight
Apr 22, 2025 07:21AM Cantor Fitzgerald Starts Merck (MRK) at Neutral
Apr 22, 2025 07:21AM Cantor Fitzgerald Starts Eli Lilly (LLY) at Overweight
Apr 22, 2025 07:20AM Cantor Fitzgerald Assumes Gilead Sciences (GILD) at Overweight
Apr 22, 2025 07:20AM Cantor Fitzgerald Starts Bristol-Myers Squibb Co. (BMY) at Neutral
Apr 22, 2025 07:19AM Cantor Fitzgerald Assumes Amgen (AMGN) at Neutral
Apr 22, 2025 07:18AM Cantor Fitzgerald Starts Abbvie (ABBV) at Overweight
Apr 22, 2025 06:01AM Form 13F-HR CANTOR FITZGERALD INVEST For: Mar 31
Apr 22, 2025 06:01AM Form EFFECT Cantor Fitzgerald Income
Apr 21, 2025 11:03AM Cantor Fitzgerald Reiterates Overweight Rating on Roivant Sciences (ROIV)
Apr 21, 2025 07:21AM Cantor Fitzgerald Reiterates Overweight Rating on Meta Platforms Inc. (META)
Apr 21, 2025 07:19AM Cantor Fitzgerald Reiterates Neutral Rating on Alphabet (GOOGL)
Apr 21, 2025 07:18AM Cantor Fitzgerald Reiterates Neutral Rating on Lyft (LYFT)
Apr 21, 2025 07:16AM Cantor Fitzgerald Reiterates Neutral Rating on Texas Instruments (TXN)
Apr 21, 2025 07:12AM Lam Research (LRCX) PT Lowered to $90 at Cantor Fitzgerald
Apr 21, 2025 07:11AM Intel (INTC) PT Lowered to $20 at Cantor Fitzgerald
Apr 21, 2025 06:55AM Cantor Fitzgerald Reiterates Overweight Rating on ServiceNow (NOW)
Apr 21, 2025 06:47AM Cantor Fitzgerald Reiterates Overweight Rating on aTyr Pharma (ATYR)
Apr 21, 2025 06:42AM Cantor Fitzgerald Reiterates Overweight Rating on Anteris Technologies Global (AVR)
Apr 21, 2025 06:40AM Cantor Fitzgerald Reiterates Overweight Rating on Nano-X Imaging (NNOX)
Apr 21, 2025 06:32AM Cantor Fitzgerald Starts Verona Pharma (VRNA) at Overweight
Apr 18, 2025 03:40PM Form POS AM Cantor Fitzgerald Income
Apr 16, 2025 04:15PM Satellogic Announces Closing of $20 Million Registered Direct Offering of Class A Common Stock
View More Recent Stories View Older Stories